Kbc Group Nv Veracyte, Inc. Transaction History
Kbc Group Nv
- $36.3 Billion
- Q4 2024
A detailed history of Kbc Group Nv transactions in Veracyte, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 3,872 shares of VCYT stock, worth $160,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,872
Previous 2,677
44.64%
Holding current value
$160,920
Previous $91,000
68.13%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VCYT
# of Institutions
320Shares Held
80.6MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$324 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$322 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$209 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$176 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$175 Million1.46% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.97B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...